Tag: Pharmaceuticals

Pricing, Regulations

Drug rebates were associated with higher out-of-pocket costs for patients

June 16, 2021

Via: Medical News

Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower drug costs for insurers has led to increases in list prices and out-of-pockets costs for patients. To investigate whether patients […]

Industry, News, Vaccines

Pfizer’s COVID-19 Vaccine Protects Against SARS-CoV-2 Variants

June 14, 2021

Via: Genetic Engineering and Biotechnology News

The good news about vaccines and variants continues to roll in. Last week, a study reported that Johnson & Johnson’s COVID-19 vaccine protected against all of the SARS-CoV-2 variants of concern. Now, Pfizer’s COVID-19 vaccine has been shown to protect […]

Industry, Vaccines

NCCN experts provide new guidance on COVID-19 vaccines for cancer patients

June 11, 2021

Via: Medical News

The National Comprehensive Cancer Network (NCCN) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert […]

FDA, Industry, News, Vaccines

Ocugen gets a black eye as FDA denies emergency OK for COVID jab

June 11, 2021

Via: Pharmaphorum

That will hold back the biotech’s Covaxin shot by several months, and the delay put pressure on Ocugen’s share price, which fell more than 25% after the announcement. The Philadelphia-based company said it had taken the decision to go down […]

Mergers and Acquisitions, News

Merck signs $1.2bn supply deal with US government for Molnupiravir

June 9, 2021


The treatment, being developed by Merck in collaboration with Ridgeback Biotherapeutics, is currently being evaluated in a phase 3 clinical trial. The trial, know as the MOVe-OUT study, is evaluating molnupiravir in the treatment of non-hospitalised patients with laboratory-confirmed COVID-19 […]

Manufacturing, Research and Development

After COVID-19 spotlighted supply chain weaknesses, Biden unveils plan to resurrect U.S. drug manufacturing

June 8, 2021

Via: FiercePharma

After investigating America’s supply chains, including those for drugs and pharmaceutical ingredients, the Biden administration has revelations to share—and it’s proposing a sweeping strategy to boost domestic drug production. Under the plan, the White House is establishing a public-private partnership […]

Biotech, Industry

Biotech raises $1.4 million to accelerate drug delivery technology

June 8, 2021

Via: EPM Magazine

CyGenica raised the money in a seed fund investment round led by global venture capital investor SOSV. CyGenica will use the funding to accelerate the validation of its technology which is designed to enable safe, targeted and affordable intercellular drug […]

Cell and Gene Therapy, Industry, News, Pharma

Iksuda Therapeutics raises $47m to progress ADC pipeline

June 7, 2021

Via: Pharma Times

This includes the company’s lead pre-clinical ADC candidate IKS03, a potentially ‘best-in-class’ CD19-targeted asset for B-cell cancers. Iksuda will use the funds to support the progression of IKS03 into first-in-human Phase I clinical trials, and will also be used to […]

Industry, Pharma

Pharma delivers: New campaign celebrates pharma distribution companies’ role during pandemic

June 4, 2021

Via: FiercePharma

Most people don’t normally think about the intricacies of the pharma supply chain, but the COVID-19 pandemic suddenly pushed the topic front and center. Now a new ad campaign from the Healthcare Distribution Alliance celebrates the critical work of healthcare […]

Industry, Vaccines

White House Lists Countries Getting First Batch of Extra COVID Vaccines

June 4, 2021


An initial 25 million doses of coronavirus vaccines will be sent out this month to a “wide range of countries” in Latin America, the Caribbean, Southeast Asia and Africa, along with the Palestinian territories, war-ravaged Gaza and the West Bank, […]

FDA, Regulations

FDA approves Alkermes’ Lybalvi for schizophrenia and bipolar I disorder

June 2, 2021

Via: Pharma Times

Lybalvi (olanzapine and samidorphan) has been authorised as maintenance monotherapy of adults with schizophrenia or bipolar I disorder, for the acute treatment of manic or mixed episodes and as monotherapy or an adjunct to lithium or valproate. In clinical trials, […]

FDA, Regulations

FDA restricts use of Intercept drug due to liver injury risk

May 27, 2021

Via: Biopharma Dive

The FDA action won’t have an immediate impact on sales of Ocaliva because the majority of patients taking the drug don’t have advanced cirrhosis, according to Intercept. The company prepared investors for the move earlier this month when it released […]